Literature DB >> 23941828

Inflammation and cancer stem cells.

Sarah Shigdar1, Yong Li2, Santanu Bhattacharya3, Michael O'Connor4, Chunwen Pu5, Jia Lin4, Tao Wang4, Dongxi Xiang4, Lingxue Kong6, Ming Q Wei7, Yimin Zhu8, Shufeng Zhou9, Wei Duan10.   

Abstract

Cancer stem cells are becoming recognised as being responsible for metastasis and treatment resistance. The complex cellular and molecular network that regulates cancer stem cells and the role that inflammation plays in cancer progression are slowly being elucidated. Cytokines, secreted by tumour associated immune cells, activate the necessary pathways required by cancer stem cells to facilitate cancer stem cells progressing through the epithelial-mesenchymal transition and migrating to distant sites. Once in situ, these cancer stem cells can secrete their own attractants, thus providing an environment whereby these cells can continue to propagate the tumour in a secondary niche.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Epigenetics; Epithelial–mesenchymal transition; Inflammation; Microenvironment

Mesh:

Substances:

Year:  2013        PMID: 23941828     DOI: 10.1016/j.canlet.2013.07.031

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  47 in total

1.  Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers?

Authors:  Abbas Ghaderi; Shabnam Abtahi
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

Review 2.  Clonal cooperativity in heterogenous cancers.

Authors:  Hengbo Zhou; Deepika Neelakantan; Heide L Ford
Journal:  Semin Cell Dev Biol       Date:  2016-08-28       Impact factor: 7.727

3.  Association between inflammation and cancer stem cell phenotype in breast cancer.

Authors:  Young Ju Jeong; Hoon Kyu Oh; Sung Hwan Park; Jin Gu Bong
Journal:  Oncol Lett       Date:  2017-12-13       Impact factor: 2.967

Review 4.  NF-κB, inflammation, immunity and cancer: coming of age.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Nat Rev Immunol       Date:  2018-01-22       Impact factor: 53.106

Review 5.  Mechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapy.

Authors:  Jin Zhang; Guan Wang; Yuxin Zhou; Yi Chen; Liang Ouyang; Bo Liu
Journal:  Cell Mol Life Sci       Date:  2018-02-07       Impact factor: 9.261

6.  Inhibitory feedback control of NF-κB signalling in health and disease.

Authors:  Jack A Prescott; Jennifer P Mitchell; Simon J Cook
Journal:  Biochem J       Date:  2021-07-16       Impact factor: 3.857

Review 7.  Modulators affecting the immune dialogue between human immune and colon cancer cells.

Authors:  Meir Djaldetti; Hanna Bessler
Journal:  World J Gastrointest Oncol       Date:  2014-05-15

Review 8.  Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment.

Authors:  Kang Li; Zeng Dan; Yu-Qiang Nie
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 9.  The Function of the Mutant p53-R175H in Cancer.

Authors:  Yen-Ting Chiang; Yi-Chung Chien; Yu-Heng Lin; Hui-Hsuan Wu; Dung-Fang Lee; Yung-Luen Yu
Journal:  Cancers (Basel)       Date:  2021-08-13       Impact factor: 6.639

Review 10.  Chemotherapy: a double-edged sword in cancer treatment.

Authors:  Nafiseh Behranvand; Farzad Nasri; Reza Zolfaghari Emameh; Pouria Khani; Asieh Hosseini; Johan Garssen; Reza Falak
Journal:  Cancer Immunol Immunother       Date:  2021-08-05       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.